Human disease biobanking in China:results from a primary survey and perspectives

Hong LIANG,Yujun ZHANG,Zuoxiang LI,Jingjing SHI,Yun ZHANG,Jian SU,Xiaomei XIANG,Shunai LIU
DOI: https://doi.org/10.3969/j.issn.2095-3097.2015.06.002
2015-01-01
Abstract:Objective To establish knowledge of the top-level framework design and interna-tional cooperation , the organization and functioning of biobanks in China by collecting the basic infor -mation and related data .Methods A questionnaire survey was applied on 11 typical disease-oriented biobanks , collecting information on the organizational structure , form of staff, specimen collection and effective usages , and sustainable development of biobanks. Results Almost all biobanks were affiliated within hospital and/or academic institution .The national and provincial government grants , the hospital special funds were the most common and largest sources of establishment funding of these biobanks .Two-third biobanks were established within the last five years .Nearly all biobanks were established intentionally to address particular or general research .The personnel structure of most biobanks was unreasonable .There were tremendous diversity in the biobank sizes and types of speci-men collections .Most biobanks had enough capability in molecular and genetic analysis , whereas their pathological and cellular detection capability was relatively weak .The underutilization of speci-mens and long-term funding of biobanks were the most important issues which should be concerned in future .Conclusion The establishment and development of human diseases biobanks in China are in rapid growth stage .The most imperative issues are to establish the top-level framework structure , strengthen the management and ethical principles , construct the international standard specimens collection and quality control level and develop the professional training .
What problem does this paper attempt to address?